Scailyte
ExitedArtificial intelligence for clinical research and diagnostics
Scailyte has raised €21M across 6 funding rounds from 3 investors, most recently a Series A round in Dec 2023. Based in Sursee, Switzerland; founded 2017; active in AI. Acquired by Hera Biotech in 2024. Data as of 28 Oct 2026.
Total raised
€21M
€21,246,611
Funding rounds
6
Investors
3
distinct backers
Active since
2018-12
latest 2023-12
Funding by year
EUR raised per yearScailyte — funding by year — interactive chart.
Data table
| Scailyte — funding by year | |
|---|---|
| 2018 | €4.9M |
| 2020 | €2.8M |
| 2022 | €6.2M |
| 2023 | €7.4M |
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-12-05 | Series A | €7.4M | — | View deal → |
| 2022-09-22 | Series A | €6.2M | — | View deal → |
| 2022-01-11 | Series A | — | — | View deal → |
| 2020-10-06 | Series A | €2.8M | Swisscom Ventures | View deal → |
| 2019-01-01 | Seed | €2.4M | Swisscom Ventures,Zürcher Kantonalbank (ZKB) | View deal → |
| 2018-12-20 | Seed | €2.4M | Swisscom Ventures,Venture Kick,Zürcher Kantonalbank (ZKB) | View deal → |
Exit
Type
acquisition
Date
Jan 2024
Value
—
Acquiror
Hera Biotech (United States of America)
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Helsing€2.9BGermany · AI
- UiPath€1.7BRomania · AI
- ElevenLabs€1.2BUK · AI
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Ineffable Intelligence€936MUK · AI
Global coverage: FundingData